ASCO Guidelines
Een podcast door American Society of Clinical Oncology (ASCO)
180 Afleveringen
-  Adjuvant Therapy for Stage II Colon Cancer Guideline UpdateGepubliceerd: 22-12-2021
-  Management of Stage III NSCLC GuidelineGepubliceerd: 22-12-2021
-  Treatment for Brain Metastases: ASCO-SNO-ASTRO GuidelineGepubliceerd: 21-12-2021
-  Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO GuidelineGepubliceerd: 13-12-2021
-  Abemaciclib with Endocrine Therapy in the Treatment of High-Risk Early Breast Cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline Rapid Recommendation UpdateGepubliceerd: 10-12-2021
-  Considerations for the Use of Steroids: Management of irAEs Guideline (Part 13)Gepubliceerd: 16-11-2021
-  Ocular Toxicities: Management of irAEs Guideline (Part 12)Gepubliceerd: 15-11-2021
-  Cardiovascular Toxicities: Management of irAEs Guideline (Part 11)Gepubliceerd: 12-11-2021
-  Hematologic Toxicities: Management of irAEs Guideline (Part 10)Gepubliceerd: 11-11-2021
-  Nervous System Toxicities: Management of irAEs Guideline (Part 9)Gepubliceerd: 10-11-2021
-  Renal Toxicities: Management of irAEs Guideline (Part 8)Gepubliceerd: 9-11-2021
-  Musculoskeletal Toxicities: Management of irAEs Guideline (Part 7)Gepubliceerd: 8-11-2021
-  Endocrine Toxicities: Management of irAEs Guideline (Part 6)Gepubliceerd: 5-11-2021
-  Lung Toxicities: Management of irAEs Guideline (Part 5)Gepubliceerd: 4-11-2021
-  Gastrointestinal Toxicities: Management of irAEs Guideline (Part 4)Gepubliceerd: 3-11-2021
-  Cutaneous Toxicities: Management of irAEs Guideline (Part 3)Gepubliceerd: 2-11-2021
-  ICPi Overview: Management of irAEs Guideline (Part 1)Gepubliceerd: 1-11-2021
-  CAR-T Cell Therapy: Management of irAEs Guideline (Part 2)Gepubliceerd: 1-11-2021
-  Immunotherapy in Patients with Locally Advanced Esophageal Carcinoma: ASCO Guideline Rapid Recommendation UpdateGepubliceerd: 18-8-2021
-  Adjuvant PARP Inhibitors in Patients with High-risk Early-Stage HER2-Negative Breast Cancer and Germline BRCA Mutations: ASCO Hereditary Breast Cancer Guideline Rapid Recommendation UpdateGepubliceerd: 3-8-2021
Explore pivotal recommendations from the latest evidence-based clinical practice guidance with ASCO Guidelines. Join us to discover essential insights and navigate the ever-evolving landscape of cancer research and treatment.
 
 